Growth Metrics

Oruka Therapeutics (ORKA) Share-based Compensation (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 69.33%
Dec 31, 2025 -59.52%
Sep 30, 2025 100.22%
Jun 30, 2025 3.97%
Mar 31, 2025 -5.18%
Dec 31, 2024 -42.78%
Sep 30, 2024 1,217.86%
Jun 30, 2024 583.00%
Mar 31, 2024 -29.08%
Dec 31, 2023 -8.44%
Sep 30, 2023 -17.65%
Jun 30, 2023 -8.33%
Mar 31, 2023 70.00%
Dec 31, 2022 23.71%
Sep 30, 2022 -43.60%
Jun 30, 2022 2.99%
Mar 31, 2022 40.34%
Dec 31, 2021 14.42%
Sep 30, 2021 -21.80%
Jun 30, 2021 -5.67%
Mar 31, 2021 683.33%
Dec 31, 2020 260.00%
Sep 30, 2020 25.00%
Jun 30, 2020 -75.00%
Mar 31, 2020 -40.74%
Dec 31, 2019 -6.90%
Sep 30, 2019 -35.56%
Jun 30, 2019 -10.00%
Mar 31, 2019 -13.79%
Dec 31, 2018 0.00%
Sep 30, 2018 -3.33%
Jun 30, 2018 -38.14%
Mar 31, 2018 -18.49%
Dec 31, 2017 0.00%
Sep 30, 2017 0.00%
Jun 30, 2017 17.82%
Mar 31, 2017 448.28%
Dec 31, 2016 -110.86%
Sep 30, 2016 45.90%
Jun 30, 2016 18.06%
Mar 31, 2016 6.90%
Dec 31, 2015 -2.68%
Sep 30, 2015 -14.86%
Jun 30, 2015 34.62%
Mar 31, 2015 -16.67%
Dec 31, 2014 -3.11%
Sep 30, 2014 -6.40%
Jun 30, 2014 8.86%
Mar 31, 2014 0.00%
Dec 31, 2013 222.45%
Sep 30, 2013 44.12%
Jun 30, 2013 -19.05%
Mar 31, 2013 -33.33%
Dec 31, 2012 -14.86%
Sep 30, 2012 -5.13%
Jun 30, 2012 -14.29%
Mar 31, 2012 19.74%
Dec 31, 2011 -3.80%
Sep 30, 2011 5.33%
Jun 30, 2011 -3.85%
Mar 31, 2011 -35.54%
Dec 31, 2010 7.08%